Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone call help ICU survivors heal? small study aims to find out

NCT ID NCT06983496

Knowledge-focused Sponsor: Malcom Randall VA Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This pilot study tests whether a pharmacist-led telehealth follow-up program is feasible for people who survived a critical illness in the ICU. About 24 adults who needed a breathing machine or stayed in the ICU for at least a week will be randomly assigned to receive either standard care or telehealth visits at one and three months after leaving the hospital. The goal is to see if this approach can be done smoothly, not yet to prove it improves health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
telehealth follow-up appointments with a clinical pharmacist and intensivist support
What this could lead to
If successful, this could show that a telehealth model for post-ICU care is practical and worth testing in a larger trial.
What could go wrong
This is a very small pilot study with only 24 participants, so results may not apply broadly. It focuses on feasibility, not on proving health benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 24 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 89 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults 18-89 years of age * Required admission to either medical or surgical ICU * Respiratory failure requiring invasive mechanical ventilation of at least 24 hours during ICU stay; or ICU stay of at least 7 days * Anticipated discharge to home after hospitalization * Consent from patients themselves or a legally authorized representative if necessary Exclusion Criteria: * Pregnancy * Incarceration/Imprisonment * Life expectancy less than 6 months or enrolled in hospice/palliative care * Anticipated discharge to skilled nursing facility, medical rehabilitation facility, or other long terms care facility * Unable to participate in telehealth

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post-intensive care syndrome (PICS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

postintensive care syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Post-intensive care syndrome (PICS)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Malcom Randall Veterans Affairs Medical Center

    RECRUITING

    Gainesville, Florida, 32608, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.